MACAELA CIRISH: Open Payments
NPI 1558886671 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 62 payments from 16 companies in 2025. Trend: 2023 $1,812 · 2024 $2,015 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $193 |
| Gilead Sciences, Inc. | 3 | $128 |
| Lilly USA, LLC | 4 | $78 |
| Novo Nordisk Inc | 3 | $76 |
| Janssen Biotech, Inc. | 4 | $75 |
| Madrigal Pharmaceuticals | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| VIVUS LLC | 3 | $46 |
| Ardelyx, Inc. | 2 | $45 |
Products named: ENTYVIO, CREON, Epclusa, Wegovy, TREMFYA, SKYRIZI, OMVOH, RINVOQ.
Industry payments across CT — which companies pay providers there.
